![Sarah Bhagat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sarah Bhagat
Director/Board Member at
Aeovian Pharmaceuticals, Inc.
Profile
Sarah Bhagat currently works at Aeovian Pharmaceuticals, Inc., as Board Member from 2019.
Dr. Bhagat also formerly worked at Inozyme Pharma, Inc., as Independent Director from 2019 to 2025, Sofinnova Investments, Inc., as General Partner from 2020 to 2022, and Atsena Therapeutics, Inc., as Chairperson.
Dr. Bhagat received her doctorate degree in 2015 from Yale University and undergraduate degree from Franklin & Marshall College.
Sarah Bhagat active positions
| Companies | Position | Start |
|---|---|---|
Aeovian Pharmaceuticals, Inc.
 Aeovian Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Director/Board Member | 01/09/2019 |
Former positions of Sarah Bhagat
| Companies | Position | End |
|---|---|---|
| INOZYME PHARMA, INC. | Director/Board Member | 01/07/2025 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Private Equity Analyst | 01/08/2022 |
Atsena Therapeutics, Inc.
 Atsena Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage gene therapy company that develops treatments for inherited retinal diseases that cause blindness | Chairman | - |
Training of Sarah Bhagat
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
91
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Franklin & Marshall College
 Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inozyme Pharma, Inc.
 Inozyme Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
Aeovian Pharmaceuticals, Inc.
Aeovian Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Atsena Therapeutics, Inc.
Atsena Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical-stage gene therapy company that develops treatments for inherited retinal diseases that cause blindness | Health Technology |
- Stock Market
- Insiders
- Sarah Bhagat
